Wilson Sonsini Goodrich & Rosati advised Venrock on IP related matters related to the transaction. Lycia Therapeutics, Inc., a biotechnology company, announced it raised $106.6 million...
Lycia Therapeutics’ $106 Million Series C Financing Round
Upstream Bio’s $200 Million Series B Financing
Wilson Sonsini Goodrich & Rosati advised Venrock Healthcare Capital Partners on IP matters related to the transaction. Upstream Bio, a clinical-stage biotech company, announced the completion of...
Venrock’s $450 Million Ninth Fund
Cooley LLP advised Venrock on the deal. Venrock announced the closing of its ninth fund at $450 million. The fund will enable the venture capital firm to...